Mika Grasso
Interim CEO & DirectorMr. Mika Grasso is Director of BioRestorative Therapies, Inc. from June 12, 2026 and as its Interim Chief Executive Officer from August 26, 2026. Mr. Grasso is Director of XORTX Therapeutics Inc. from March 24, 2026 and as its Co-CEO from June 2026. Mr. Grasso served as Independent Director of Nuwellis, Inc. from January 21, 2026 to March 26, 2026. He is an Investment Manager at a private family office. Prior to serving as an Investment Manager, he served as a Finance Associate for Zions Capital Markets from November 2023 until March 2025, Investment Banking Associate at Paulson Investment Company from February 2022 until November 2023, Analyst at Goldman Sachs from August 2021 to February 2022 and as an Analyst on the Real Assets Team at Power Systems Management from May 2020 to August 2021. Mr. Grasso received his MS in Finance with a concentration in Investment Management and BS in Business Administration from the University of Colorado Boulder, Leeds School of Business.
Positions
- Company NameBioRestorative Therapies, Inc.Stock CodeBRTXPositionInterim CEO & Director
- Company NameXORTX Therapeutics Inc.Stock CodeXRTXPositionCo-CEO & DirectorColleagues
- AWAllen Warren DavidoffFounder, Co-CEO, President & Director
- MSMichael Scott BumbyChief Financial Officer
- SHStephen HaworthChief Medical Officer
- SEStacy EvansChief Business Officer
- MGMika GrassoCo-CEO & Director
- RJRichard J. JohnsonMember of Clinical Advisory Board
- PBPetter BjornstadMember of Clinical Advisory Board
- ARAnjay RastogiMember of the Clinical Advisory Board
